106 related articles for article (PubMed ID: 2846366)
1. Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.
Coleman RE; Fogelman I; Rubens RD
Eur J Surg Oncol; 1988 Oct; 14(5):423-8. PubMed ID: 2846366
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
[TBL] [Abstract][Full Text] [Related]
3. Familial benign hypercalcaemia. Study of a large family.
Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
[TBL] [Abstract][Full Text] [Related]
4. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
[TBL] [Abstract][Full Text] [Related]
5. Expression of the calcium receptor in human breast cancer--a potential new marker predicting the risk of bone metastases.
Mihai R; Stevens J; McKinney C; Ibrahim NB
Eur J Surg Oncol; 2006 Jun; 32(5):511-5. PubMed ID: 16564154
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
Bundred NJ; Walls J; Ratcliffe WA
Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
[TBL] [Abstract][Full Text] [Related]
8. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials in metastatic breast cancer to bone: past--present--future.
Body JJ
Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
[TBL] [Abstract][Full Text] [Related]
10. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer.
Buchs N; Bonjour JP; Rizzoli R
J Clin Endocrinol Metab; 1998 May; 83(5):1535-41. PubMed ID: 9589651
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer-associated hypercalcaemia: a reassessment of renal calcium and phosphate handling.
Gallacher SJ; Fraser WD; Patel U; Logue FC; Soukop M; Boyle IT; Ralston SH
Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():551-6. PubMed ID: 1964370
[TBL] [Abstract][Full Text] [Related]
12. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
[TBL] [Abstract][Full Text] [Related]
13. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
Ralston SH; Fogelman I; Gardiner MD; Boyle IT
Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for the development of bone metastases and hypercalcaemia in patients with breast cancer.
Powles TJ
Proc R Soc Med; 1977 Mar; 70(3):199-201. PubMed ID: 323867
[No Abstract] [Full Text] [Related]
15. Hypercalcemia in breast cancer. Reassessment of the mechanism.
Isales C; Carcangiu ML; Stewart AF
Am J Med; 1987 Jun; 82(6):1143-7. PubMed ID: 3037897
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
17. Calcium metabolism in breast cancer.
Coombes RC; Powles TJ; Joplin DG
Proc R Soc Med; 1977 Mar; 70(3):195-9. PubMed ID: 870901
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA; Guise TA
Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
[TBL] [Abstract][Full Text] [Related]
19. Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.
Ralston SH; Boyce BF; Cowan RA; Gardner MD; Dryburgh FJ; Boyle IT
Q J Med; 1986 Mar; 58(227):325-35. PubMed ID: 3016790
[TBL] [Abstract][Full Text] [Related]
20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
